The landscape of modern medicine is currently undergoing a quiet but profound revolution. For decades, the dominant medical narrative has suggested that chronic physical pain must stem from structural damage and that psychiatric distress is the result of irreversible chemical imbalances. However, a growing body of neuroscience is challenging these orthodoxies, suggesting that the brain itself—operating through a mechanism called "predictive processing"—often creates real, debilitating symptoms as a protective response to perceived danger.
In a recent episode of the Mad in America podcast, host Brooke Siem, author of the antidepressant withdrawal memoir May Cause Side Effects, sat down with Dr. Howard Schubiner to discuss this paradigm shift. Dr. Schubiner, an internist and clinical professor at the Michigan State University College of Human Medicine, has spent over two decades researching how the brain generates symptoms of chronic pain, fatigue, anxiety, and depression. His work suggests that many conditions labeled as "incurable" or "treatment-resistant" are actually "neuroplastic"—meaning they are brain-generated and, crucially, reversible.
Main Facts: The Neuroplastic Theory of Symptom Generation
The core of Dr. Schubiner’s thesis, detailed in his book Unlearn Your Pain, is that the brain is not merely a passive receiver of sensory information. Instead, it is an active architect of our reality. According to Schubiner, the brain creates real physical symptoms automatically. These are not "imagined" or "all in one’s head" in the pejorative sense; they are physiologically real sensations produced by a subconscious brain that believes the body is under threat.
This "danger signal" mechanism is rooted in the brain’s primary directive: survival. Just as the brain creates the visual world we see or the sounds we hear, it also creates the pain we feel. High-level neuroscience indicates that emotional pain activates the same neural pathways as physical pain. Consequently, a history of trauma, repressed emotions, or even chronic "people-pleasing" can cause the brain to enter a state of high alert, manifesting as back pain, migraines, irritable bowel syndrome (IBS), or clinical depression.
Schubiner identifies these as neuroplastic symptoms—neural circuits that have become "stuck" in an auto-loop. Because these circuits are learned, they can also be unlearned. This perspective offers a radical departure from the traditional model, which often seeks to "fix" the body through surgery or "rebalance" the brain through lifelong medication.
Chronology: From Dr. Sarno to Randomized Controlled Trials
The evolution of Dr. Schubiner’s work began with the pioneering insights of Dr. John Sarno, the late New York University physician who authored Mind Over Back Pain. Dr. Sarno was among the first to suggest that most back pain was not caused by structural issues like herniated discs, but by "Tension Myositis Syndrome" (TMS)—a physical manifestation of repressed psychological stress.
Dr. Schubiner, who had already established an 18-year career as a medical school faculty member and researcher, encountered Sarno’s work mid-career. Struck by its efficacy, Schubiner became a protégé of Sarno, eventually moving beyond anecdotal evidence to subject these theories to the rigors of modern clinical science.
Over the last 23 years, Schubiner has transitioned from observation to high-level validation. His research has expanded into randomized controlled trials (RCTs), the gold standard of medical evidence. These studies have compared neuroplasticity-based treatments—such as Pain Reprocessing Therapy (PRT) and Emotional Awareness and Expression Therapy (EAET)—against traditional Cognitive Behavioral Therapy (CBT) and standard medical care. The results have consistently shown that addressing the brain’s predictive processing is often superior to standard therapies for chronic pain and co-occurring psychiatric distress.
Supporting Data: The Power of Placebo and the "N of 1" Trial
To understand how the brain generates symptoms, Schubiner points to the profound data surrounding the placebo and nocebo effects. In clinical trials for antidepressants, for example, the "placebo effect" is often as high as the efficacy of the drug itself. This suggests that the belief in recovery can trigger the brain to rewire its own neural circuits.
The Nocebo Effect and Predictive Processing
Conversely, the "nocebo effect" demonstrates how expectation can create illness. Schubiner cites a dramatic case of a suicidal man in a research trial who attempted to overdose by swallowing a full bottle of pills. He arrived at the hospital with life-threatening symptoms: dangerously low blood pressure and a weak pulse. However, researchers soon discovered the man was in the placebo arm of the study; the "overdose" consisted of sugar pills. Once the patient was informed that the pills were harmless, his symptoms vanished almost instantly. His brain had predicted a fatal outcome and produced the physiological reality to match it.
Empirical Evidence in Veterans
Schubiner highlights a study conducted by his colleague, Brandon Yarns at UCLA, involving veterans who had suffered from musculoskeletal pain for over 20 years. Surprisingly, the patients who benefited most from Emotional Awareness and Expression Therapy (EAET) were those with co-existing anxiety, depression, and PTSD. This contradicts the conventional medical wisdom that patients with multiple comorbidities are the most "difficult" to treat. In Schubiner’s model, these comorbidities are evidence of a highly sensitized "danger" response in the brain, making them ideal candidates for neuroplastic retraining.
Official Responses and the Critique of Psychiatric Orthodoxy
A significant portion of Dr. Schubiner’s work involves challenging the "chemical imbalance" narrative that has dominated psychiatry for decades. He notes that the theory of low serotonin levels causing depression has no substantial scientific evidence, yet it remains the primary justification for long-term antidepressant use.
The Problem with "Treatment-Resistant" Labels
Schubiner argues that the medical community often inadvertently harms patients by providing "nocebo" messages. When a doctor tells a patient they have "degenerative disc disease" (a term Schubiner dislikes, as most people over 30 have some disc wear without pain) or "treatment-resistant depression," they are reinforcing the brain’s danger signals. These labels suggest the body or brain is "broken," which increases the subconscious fear that fuels chronic symptoms.
The Medical Gap
The primary challenge to the widespread adoption of Schubiner’s methods is a lack of awareness among practitioners. Most physicians are trained to look for structural damage (on MRIs or X-rays) or chemical deficits. When these are not found, patients are often told their pain is "idiopathic" or that they must simply "manage" it for the rest of their lives. Schubiner’s work suggests that instead of managing the symptoms, doctors should be looking for the emotional and psychological triggers that have caused the brain to "wire" these symptoms into existence.
Implications: A New Path for Mental Health and Withdrawal
The implications of Dr. Schubiner’s work are particularly relevant for those navigating antidepressant withdrawal. Brooke Siem noted that many people in withdrawal become hyper-reactive to triggers, fearing that every "wave" of symptoms is a sign of permanent brain damage.
The "N of 1" Trial for Tapering
Schubiner proposes a scientific approach to tapering medication: the "N of 1" trial. To distinguish between true physiological withdrawal and nocebo-driven symptoms caused by fear, a patient can work with a partner to "blind" their daily dose. If the symptoms occur randomly regardless of whether the dose was lowered or kept stable, the symptoms are likely neuroplastic—driven by the brain’s expectation of distress. If the symptoms correlate strictly with the lower dose, they are physiological. This empowers patients to move forward with confidence, knowing which symptoms can be "talked down" through neuroplastic techniques.
Reclaiming Agency through PRT and EAET
The therapeutic interventions Schubiner champions—Pain Reprocessing Therapy (PRT) and Emotional Awareness and Expression Therapy (EAET)—focus on three pillars:
- Agency: The belief that the individual has the power to change their internal state.
- Connection: Reconnecting with one’s authentic self and suppressed emotions.
- Self-Compassion: Replacing self-criticism (a major danger signal) with kindness.
PRT involves "graded exposure" to triggers, teaching the brain through mindfulness and affirmations that a stimulus (like driving or sitting) is not actually dangerous. EAET goes deeper, helping patients safely experience and express suppressed emotions like anger or sadness, which often act as the "fuel" for the brain’s danger signals.
Conclusion: The Horizon of Recovery
Dr. Schubiner’s work offers a message of profound hope for the millions of people currently categorized as "chronically ill." By shifting the focus from structural damage to neural circuit retraining, the medical field may finally have the tools to address the root causes of the modern epidemic of chronic pain and mental distress.
As Schubiner concludes, "Getting stuck in the idea that everything is structural and everything is incurable is a horrible place to be. For the vast majority of people, there is hope." By understanding the brain not as a broken machine, but as a protective, adaptable architect, patients can begin the work of "unlearning" their pain and reclaiming their lives.
